| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 2.70 | Low level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. (Feb 2024) |
| Mutant | Resistances |
|---|---|
| E596del |
Ganciclovir:
|
| E596G |
Ganciclovir:
|
| E596Y |
Ganciclovir:
|